Medscape www.medscape.com

References for:
Orbital Rhabdomyosarcoma

[Cancer Care 11(5):328-333, 2004. © 2004 Cancer Care, Inc.]

  1. Gurney JG,Young Jr JL, Roffers SD, et al. Soft tissue sarcomas. In: Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, Md: National Cancer Institute; 1999. National Institutes of Health publication NIH 99-4649.
  2. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993;71:1904-1922.
  3. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995;13:610-630.
  4. Wexler LH, Crist WM, Helman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DG, eds. Principals and Practice of Pediatric Oncology. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001.
  5. Frezzotti R, Hadjistilianou T, Tosi P. Rhabdomyosarcoma of the orbit: clinical and histopathological analysis of a personal series of 19 cases. Orbit. 1990;9:307-312.
  6. Shields JA, Shields CL. Rhabdomyosarcoma: review for the ophthalmologist. Surv Ophthalmol. 2003;48:39-57.
  7. Kodet R, Newton WA Jr, Hamoudi AB, et al. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis. An Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol. 1997;29:51-60.
  8. Newton WA Jr, Gehan EA,Webber BL, et al. Classification of rhabdomyosarcomas and related sarcomas. Cancer. 1995;76:1073-1085.
  9. Margo CE, Karcioglu ZA. Diagnostic electromicroscopy. In: Karcioglu ZA, ed. Laboratory Diagnosis in Ophthalmology.New York,NY: Macmillan Publishing Co; 1987.
  10. Warner MA, Weber AL, Jakobiec FA. Benign and malignant tumors of the orbital cavity including the lacrimal gland. Neuroimaging Clin N Am. 1996;6:123-142.
  11. Sohaib SA, Moseley I, Wright JE. Orbital rhabdomyosarcoma: the radiological characteristics. Clin Radiol. 1998;53:357-362.
  12. Cota N, Chandna A,Abernethy LJ. Orbital abscess masquerading as a rhabdomyosarcoma. J AAPOS. 2000;4:318-320.
  13. Mafee MF, Pai E, Philip B. Rhabdomyosarcoma of the orbit: evaluation with MR imaging and CT. Radiol Clin North Am. 1998;36: 1215-1227.
  14. DePotter P, Shields CL, Shields JA. Myogenic tumors. In: DePotter P, Shields JA, Shields CL, eds. MRI of the Eye and Orbit. Philadelphia, Pa: Lippincott Williams and Wilkins; 1995.
  15. Wende S,Aulich A, Nover A, et al. Computed tomography of orbital lesions: a comparative study of 210 cases. Neuroradiology. 1977; 13:123-134.
  16. Scotti G, Harwood-Nash DC. Computed tomography of rhabdomyosarcomas of the skull base in children. J Comput Assist Tomogr. 1982;6:33-39.
  17. Sartor K, ed. MR Imaging of the Skull and Brain: A Correlative Text-Atlas. Berlin, New York, NY: Springer-Verlag; 1992.
  18. Cooper S, Munk PL, Downey DB, et al. Findings of magnetic resonance and colour-flow Doppler imagining of orbital embryonal rhabdomyosarcoma. Can Assoc Radiol J. 1994;45:217-220.
  19. Yang WT, Kwan WH, Li CK, et al. Imaging of pediatric head and neck rhabdomyosarcomas with emphasis on magnetic resonance imaging and a review of the literature. Pediatr Hematol Oncol. 1997;14:243-257.
  20. Karcioglu ZA, Haik BG. Staging of orbital tumors. In: Karcioglu ZA, ed. Orbital Tumors: Diagnosis and Treatment. New York, NY: Springer-Verlag; 2004.
  21. Shields CL, Shields JA, Honavar SG, et al. Clinical spectrum of primary ophthalmic rhabdomyosarcoma. Ophthalmology. 2001;108: 2284-2292.
  22. Cassady JR. How much is enough? The continuing evolution of therapy in childhood rhabdomyosarcoma and its refinement. Int J Radiat Oncol Biol Phys. 1995;31:675-676.
  23. Jones IS, Reese AB, Krout J. Orbital rhabdomyosarcoma: an analysis of sixty-two cases. Trans Am Ophthamol Soc. 1965;63:223-255.
  24. Frayer WC, Enterline HT. Embryonal rhabdomyosarcoma of the orbit in children and young adults. Arch Ophthalmol. 1959;62: 203-210.
  25. Sagerman RH, Cassady JR, Tretter P. Radiation therapy for rhabdomyosarcoma of the orbit. Trans Am Acad Ophthalmol Otolaryngol. 1968;72:849-854.
  26. Abramson DH, Ellsworth RM, Tretter P. The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy. Ophthalmology. 1979;86:1330-1335.
  27. Jereb B, Haik BG. Parameningeal rhabdomyosarcoma (including the orbit): results of orbital irradiation. Int J Radiat Oncol Biol Phys. 1985;11:2057-2065.
  28. Sutow WW, Lindberg RD, Gehan EA, et al. Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck: report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1982;49:2217-2221.
  29. Heyn R, Ragab A, Raney RB Jr, et al. Late effects of therapy in orbital rhabdomyosarcoma in children: a report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1986;57:1738-1743.
  30. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I: a final report. Cancer. 1988;61:209-220.
  31. Wharam MD, Hanfelt JJ,Tefft MC, et al. Radiation therapy for Rhabdomyosarcoma: local failure risk for clinical group III patients on Intergroup Rhabdomyosarcoma Study II. Int J Radiat Oncol Biol Phys. 1997;38:797-804.
  32. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma: Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol. 1993;11:262-270.
  33. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091-3102.
  34. Rousseau P, Flamant F, Quintana E, et al. Primary chemotherapy in rhabdomyosarcoma and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 study. J Clin Oncol. 1994;12:516-521.
  35. Notis CM, Abramson DH, Sagerman RH, et al. Orbital rhabdomyosarcoma: treatment and overtreatment. Ophthalmic Genet. 1995;16:159-162.
  36. Michalski JM, Sur RK, Harms WB, et al. Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys. 1995;33:985-991.
  37. Raney RB,Anderson JR, Kollath J, et al. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 19841991. Med Pediatric Oncol. 2000;34:413-420.
  38. Breneman JC, Wiener ES. Issues in the local control of rhabdomyosarcoma. Med Pediatric Oncol. 2000;35:104-109.
  39. Hug EB, Adams J, Fitzek M, et al. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys. 2000;47:979-984
  40. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment: results of an international workshop. J Clin Oncol. 2001;19:197-204.
  41. Ducrey N, Nenadov-Beck M, Spahn B. Update of orbital rhabdomyosarcoma therapy in children [in French]. J Fr Ophthalmol. 2002;25:298-302.
  42. Fiorillo A, Migliorati R,Vassallo P, et al. Radiation late effects in children treated for orbital rhabdomyosarcoma. Radiother Oncol. 1999;53:143-148.